Medline Inc. MDLN
- Employees
- 45,000
- Headquarters
- Northfield, IL
- CEO
- James M. Boyle
- Next results
- around Feb 24, 2027
Where each dollar of revenue went, FY2025
Revenue of $28.4B through the costs to a net profit of $1.2B · income statement of the 10-K
MDLN among Health care peers
Six ratios from the latest 10-K. Each corner is the share of 154 peers the company is above, not a score.
What changed
Nothing new in the latest 10-K.
Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.
Accounting checks
9 checks on the latest 10-K. Checks, not verdicts.
0facts worth reading about all 9 checks found nothing to note
-
Receivables +9.8% ($3.2B to $3.5B) vs revenue +11.5% ($25.5B to $28.4B), -1.7 pts apart
-
Inventory +7.0% ($4.5B to $4.8B) vs revenue +11.5% ($25.5B to $28.4B), -4.4 pts apart
-
Auditor names not available for both 10-Ks; no 8-K item 4.01
6 more checks with nothing to note
-
No statement of substantial doubt about going concern
-
No 8-K item 4.02 in the last 2 years
-
No NT 10-K or NT 10-Q in the last 2 years
-
No sentence in the 10-K concludes that controls were not effective because of a material weakness
-
No 8-K item 2.06 in the last 2 years
-
No 8-K item 1.03 in the last 2 years
In their words
No new paragraphs in Risk Factors
No new paragraphs in Risk Factors, or fewer than two 10-Ks to compare.
Financial performance
Last 3 fiscal years · 10-K XBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | $23.2B | $25.5B | $28.4B |
| Net income | $234.0M | $1.2B | $1.2B |
| Operating cash flow | $1.7B | $1.8B | $1.7B |
| Free cash flow | $1.4B | $1.4B | $1.3B |
Revenue, FY2023 to FY2025
Ten fiscal years, each from its own 10-K · XBRL · USD
$28.4B ▲ 11.5% in FY2025$1.2B ▼ 0.3% in FY2025$1.3B ▼ 8.3% in FY2025
Recent filings
6 filings in the last 30 days · SEC EDGAR
-
Planned saleNov 13, 2026Stephen Miller (Officer) gave notice of a planned sale of 39,819 shares worth about $1.6M Form 144, approximate sale date Nov 13, 2026
-
Planned saleNov 13, 2026Stephen Miller (Officer) gave notice of a planned sale of 39,819 shares worth about $1.6M Form 144, approximate sale date Nov 13, 2026
-
Planned saleNov 4, 2026Stephen L. Miller (Former Chief Operating Officer) ended a 10b5-1 trading plan reported in the 10-Q, up to 808,451 shares
-
8-KNov 4, 2026Quarterly results 8-K item 2.02
-
10-QNov 4, 2026Quarterly report (10-Q) period ended Sep 26, 2026
About the company
Medline Inc., Northfield, IL · from the 10-K filed Feb 25, 2026
Medline Inc. (together with its subsidiaries, “Medline”, “the Company”, “we”, “ours” and “us”) is the largest provider of medical-surgical (“med-surg”) products and supply chain solutions serving all points of care, based on total net sales of med-surg products. Medline was founded in 1966 and today delivers mission-critical products used daily across the full range of care settings, from hospitals and surgery centers to physician offices and post-acute facilities. Our mission is to make healthcare run better by delivering improved clinical, financial, and operational outcomes.
- Headquarters
- Northfield, IL
- Country
- United States
- Reports in
- USD
- Listed on
- Nasdaq
- Fiscal year ends
- December 31
- Last results
- Nov 4, 2026
- Incorporated in
- DE
Employees, at the top of the page: "As of December 31, 2025, we employed over 45,000 employees worldwide, with over 26,000 located in the United States" (10-K). Address and exchange: SEC's company file.
Email alerts
Sources
Numbers from the XBRL of the 10-Ks; filings from SEC EDGAR.
Work with it: Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/MDLN/export.csv") into a cell.